Common Contracts
2 similar Common Stock Purchase Warrant contracts by Idera Pharmaceuticals, Inc.
THIS WARRANT AND THE SHARES OF COMMON STOCK ISSUED UPON ITS EXERCISE ARE SUBJECT TO THE RESTRICTIONS ON TRANSFER SET FORTH IN SECTION 5 OF THIS WARRANT AND ARTICLE 6 OF THE PURCHASE AGREEMENTCommon Stock Purchase Warrant • November 14th, 2012 • Idera Pharmaceuticals, Inc. • Biological products, (no disgnostic substances) • Delaware
This Warrant is one in a series of warrants (the “Series Warrant”) issued pursuant to that certain Convertible Preferred Stock and Warrant Purchase Agreement, dated November 9, 2012, among the Company, the Registered Holder and the other parties thereto (the “Purchase Agreement”).
THIS WARRANT AND THE SHARES OF COMMON STOCK ISSUED UPON ITS EXERCISE ARE SUBJECT TO THE RESTRICTIONS ON TRANSFER SET FORTH IN SECTION 5 OF THIS WARRANTCommon Stock Purchase Warrant • November 10th, 2011 • Idera Pharmaceuticals, Inc. • Biological products, (no disgnostic substances) • Massachusetts
Idera Pharmaceuticals, Inc., a Delaware corporation (the “Company”), for value received, hereby certifies that ______________________, or its registered assigns (the “Registered Holder”), is entitled, subject to the terms and conditions set forth below, to purchase from the Company, at any time or from time to time on or after the date of issuance and on or before 5:00 p.m. (Boston time) on November __, 2016, _________ shares of Common Stock, $0.001 par value per share, of the Company (“Common Stock”), at a purchase price of $_______ per share. The shares purchasable upon exercise of this Warrant, and the purchase price per share, each as adjusted from time to time pursuant to the provisions of this Warrant, are hereinafter referred to as the “Warrant Shares” and the “Purchase Price,” respectively.
